Therapeutic effects of an oral gonadotropin‐releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF

Therapeutic effects of an oral gonadotropin‐releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF

Abstract Purpose Can relugolix, a novel oral gonadotropin‐releasing hormone receptor (GnRH) antagonist, function as an alternative ovulation inhibitor to GnRH antagonist injections? Methods This single‐center, cross‐sectional retrospective study compared premature ovulation rates and clinical outcom...

Full description

Bibliographic Details
Main Authors: Kazuki Nakao, Keiji Kuroda, Takashi Horikawa, Azusa Moriyama, Hiroyasu Juen, Akiko Itakura, Hideaki Watanabe, Satoru Takamizawa, Yuko Ojiro, Koji Nakagawa, Rikikazu Sugiyama
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Reproductive Medicine and Biology
Subjects:
Gonadotropin‐releasing hormone receptor antagonist
in vitro fertilization
mild ovarian stimulation
premature ovulation
relugolix
Online Access:https://doi.org/10.1002/rmb2.12422

Internet

https://doi.org/10.1002/rmb2.12422

Similar Items